Professor Stan Kaye
- Consultant Medical Oncologist
- Head of Drug Development Unit
- BSc
- MD
- FRCP
- FRCR
- FRSE
- FMedSci
Biography
Professor Stan Kaye is currently Head of the Drug Development Unit and Head of the Section of Medicine at The Royal Marsden Hospital and The Institute of Cancer Research. He was also Head of the Gynaecology Unit at The Royal Marsden. He is now responsible for one of the world’s largest Phase I units, incorporating ten inpatient and five outpatient beds, over 80 staff and over 30 current new drug trials. Between 250 and 300 patients per year now enter Phase I trials in the Drug Development Unit.
Professor Kaye joined The Royal Marsden in September 2000 after 20 years in Glasgow (15 years of which were spent as Head of Medical Oncology at the university there). He qualified in medicine in 1972 in London, and completed training in medicine and oncology in London and Australia.
His major interests, apart from new drug development, are in ovarian cancer and drug resistance. He now shares responsibility with Professor Martin Gore for the care of patients with gynaecological cancer at The Royal Marsden.
The author of over 350 peer-reviewed papers, he sits on the Editorial Board of 12 cancer journals, and has held various national and international responsibilities, most notably in Cancer Research UK (the world’s largest cancer charity) for which he previously chaired the Clinical and Translational Research Committee.
Clinical teams